“…Contact between the agonist and the receptor triggers a PLC/IP 3 -pathway-type complex chain reaction which, via the activation of numerous enzymes and the increase in the concentration of H + and cytosolic Ca 2+ (respectively (H + ) c and (Ca 2+ ) c ), culminates with degranulation, by the exocytotic secretion of allergic mediators and the onset of an acute allergic response. The responses of the various agonist/receptor couples may differ [ 69 , 77 , 84 ], but depend in each case on the concentration and affinity of the agonist [ 74 ], and the fundamental steps in the basic biochemical mechanism of allergic reactions do not vary ( Figure 1 ): - The stimulation of the receptor, both of the FcεRI and GPCR types, activates phospholipase C (PLC) [ 85 , 86 , 87 , 88 ] and hence the hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP 2 ) on the inner wall of the plasma membrane, generating and releasing IP 3 , a protonated acid salt [ 62 , 89 ], in the cytosol;
- Through dissociation, the IP 3 releases H + [ 62 , 89 ] and, via its IP 3 R receptor, induces cell calcium release and store depletion, increasing (Ca 2+ ) c [ 62 , 90 ];
- The increase in (Ca 2+ ) c activates numerous calcium-dependent enzymes, including phospholipase A 2 (PLA 2 ), which produces arachidonic acid (AA) [ 91 , 92 ], which in turn dissociates releasing more H + and inducing the release of more Ca 2+ [ 56 , 58 , 93 ]; from the AA hundreds of derivatives (eicosanoids cascade) are formed, including leukotrienes (LTs) and prostaglandins (PGs) [ 94 , 95 ]. Both leukotrienes and prostaglandins are known to play a pivotal role in inflammatory and allergic reactions;
- The store depletion stimulates the entry of more Ca 2+ from the extracellular space (calcium influx) via the mechanism known as Store Operated Calcium Entry (SOCE), in which, from the surface of the Endoplasmic Reticulum (ER), Stromal Interaction Molecule1 (STIM1) activates the opening of ORAI1 and Transient Receptor Potential Cation Canonical (TRPC) [
…”